James Brady
Net worth: 929 615 $ as of 31/08/2026
Net worth: 929 615 $ as of 31/08/2026
James P.
Brady is currently Chief Human Resources Officer at Ardelyx, Inc. since 2025.
Formerly, Mr. Brady was Chief Human Resources Officer at Spero Therapeutics, Inc., Vice President-Human Resources at Intarcia Therapeutics, Inc. from 2015 to 2020, and Chief Human Resources Officer at uniQure NV from 2020 to 2021.
Education includes graduate studies at Harvard University and undergraduate studies at Marietta College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 0.1% | 21/08/2026 | 245,930 ( 0.1% ) | 929 615 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Human Resources Officer | 02/06/2025 |
| Companies | Position | End |
|---|---|---|
| UNIQURE N.V. | Human Resources Officer | 01/09/2021 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Human Resources Officer | 01/08/2020 |
| SPERO THERAPEUTICS, INC. | Human Resources Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marietta College
Marietta College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Select your edition
All financial news and data tailored to specific country editions